Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QiShen YiQi Dripping Pills in Diabetic Kidney Disease
NCT06006689Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Sep 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of qishen yiqi dripping pills in diabetic kidney disease (DKD), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Sep 2023; status: completed.
02
Drugs
qishen yiqi dripping pills
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT06006689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06006689.